Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01995097 · ClinicalTrials.gov registry record · NA
BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 331
- Enrollment target
NCT01995097 is a NA study that has completed, run by Duke University. The registered enrollment target is 331 participants.
The verdict
NCT01995097, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 331 participants
- Enrollment target
Study Summary
Primary Aim: To test the efficacy of a SMS text-based scheduled gradual reduction (SGR) and counseling intervention to promote smoking cessation in the late third trimester. Hypothesis: The rate of smoking cessation in the late third trimester among women in the SGR Support Messages arm will be higher than among women in the Support Messages arm. Secondary Aim 1: To assess the effect of the SGR intervention on biochemically validated prolonged abstinence and smoking reduction during pregnancy. Secondary Aim 2: To assess the effect of the SGR intervention on smoking abstinence at three months postpartum. Secondary Aim 3: To assess the effect of the SGR intervention on the rate of preterm birth.
Interventions
- BEHAVIORAL Scheduled Gradual Reduction Text Messages
- BEHAVIORAL Support Text Messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01995097
The ClinicalTrials.gov registry entry for NCT01995097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 331 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scheduled Gradual Reduction Text Messages is the first listed.
NCT01995097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01995097 about?
NCT01995097 is a clinical study titled "BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit". Primary Aim: To test the efficacy of a SMS text-based scheduled gradual reduction (SGR) and counseling intervention to promote smoking cessation in the late third trimester. Hypothesis: The rate of smoking cessation in the late third trimester among women in the SGR Support Messages arm will be hig...
What is the current status of trial NCT01995097?
This trial is currently completed. It is a NA study. The enrollment target is 331 participants. The study started on 2014-03. Estimated completion is 2018-02-20.
What interventions are being tested in trial NCT01995097?
The interventions under investigation include: Scheduled Gradual Reduction Text Messages (BEHAVIORAL), Support Text Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT01995097?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.